한글목차

세계의 플라즈마 의료 시장 전망은 생물학적 오염 제거, 치료 용도 및 기타 시장에서의 기회로 인해 유망한 전망을 보이고 있습니다. 세계 플라즈마 의료 시장은 2025-2031년 연평균 복합 성장률(CAGR) 15.2%를 보일 것으로 예측됩니다. 이 시장의 주요 촉진요인은 상처 치유 및 암 치료에서 비침습적 치료법에 대한 수요 증가, 감염 관리 및 생물학적 오염 제거 방법에 대한 관심 증가, 맞춤형 의료에 대한 관심 증가 등입니다.

• Lucintel의 예측에 따르면 유형별로는 유도 결합형 방전 방식이 예측 기간 중 가장 높은 성장률을 보일 것으로 예측됩니다.
• 용도별로는 치료용이 가장 높은 성장률을 보일 것으로 예측됩니다.
• 지역별로는 아시아태평양(APAC)이 예측 기간 중 가장 높은 성장률을 보일 것으로 예측됩니다.

플라즈마 의료 시장의 새로운 동향

플라즈마 의료 시장은 그 응용 분야와 성장 가능성을 재구성하는 몇 가지 새로운 동향과 함께 진화하고 있습니다. 주요 동향으로는 플라즈마 기반 기술의 주류 의료에 대한 통합, 비침습적 치료에 대한 관심 증가, 맞춤형 의료의 부상, 플라즈마 멸균 기술의 발전, 연구 및 임상시험 증가 등이 있습니다.

• 비침습적 치료 및 치료법: 플라즈마 의료는 비침습적 특성으로 인해 특히 상처 치유 및 피부과 영역에서 주목받고 있습니다. 플라즈마 기반 치료법은 외과적 개입 없이도 질병을 치료할 수 있도록 고안된 치료법입니다. 이러한 추세는 환자 치료의 변화를 가져와 치료 접근성을 높이고 회복 기간을 단축하고 있습니다. 플라즈마 기술의 비침습적 특성은 전 세계에서 플라즈마 기반 의료기기의 채택 확대에 기여하고 있습니다.
• 플라즈마 멸균 기술의 발전: 플라즈마 기반 멸균 기술은 의료 분야, 특히 수술 기구 및 병원 환경의 멸균에서 점점 더 널리 보급되고 있습니다. 플라즈마 멸균은 기존 방식보다 효율적이고 환경 친화적이라는 장점을 제공합니다. 감염 위험 감소, 의료 관련 비용 절감, 전체 환자 치료 결과 개선으로 이어질 수 있으며, 의료 및 공중보건 분야의 중요한 동향이 되고 있습니다.
• 플라즈마 기반 암 치료: 플라즈마 의료는 종양학 분야로 확대되고 있으며, 암세포 치료에 플라즈마 활용이 연구의 초점이 되고 있습니다. 연구에 따르면 플라즈마는 암세포의 세포 사멸을 유도할 수 있으며, 기존의 암 치료법을 대체할 수 있는 유망한 비침습적 대안이 될 수 있습니다. 현재 진행 중인 임상시험과 실험 연구가 혈장 기반 암 치료의 길을 열고 있으며, 이 새로운 동향은 향후 암 치료에 혁명을 가져올 수 있습니다.
• 개인맞춤형 플라즈마 의료: 맞춤형 의료 동향은 환자의 특정 요구에 맞게 치료를 조정하는 플라즈마 치료법 개발에 영향을 미치고 있습니다. 플라즈마 의료는 다양한 피부질, 상처 상태, 질환에 따라 맞춤형 치료가 가능하여 치료 효과를 높일 수 있습니다. 연구가 진행됨에 따라 플라즈마 치료는 환자의 고유한 요구 사항을 충족하는 형태로 점점 더 많이 적용되어 치료 결과와 만족도를 향상시키는 데 기여할 것입니다.
• 연구개발 및 임상시험 증가: 연구개발에 대한 투자 확대와 임상시험 수 증가가 맞물려 플라즈마 의료의 성장을 가속화하고 있습니다. 연구기관, 병원, 제약회사들은 플라즈마의 작용 메커니즘과 다양한 응용을 더 깊이 이해하기 위해 연구에 투자하고 있습니다. 임상시험 증가는 혈장 기반 의료 제품의 혁신과 상용화를 촉진하고 시장 성장을 가속할 가능성이 높습니다.

이러한 새로운 동향은 플라즈마 의료 시장을 크게 변화시키고 있습니다. 플라즈마 치료의 비침습성은 환자 경험을 향상시키는 동시에 플라즈마 멸균 기술 및 암 치료의 발전은 의료 분야 전반에 광범위한 영향을 미치고 있습니다. 맞춤형 의료와 임상시험 증가는 혁신과 보급을 가속화하고 시장 상황을 재구성하여 혈장 기반 치료법의 광범위한 수용과 활용에 기여할 것입니다.

플라즈마 의료 시장의 최근 동향

플라즈마 의료 시장은 기술 혁신, 새로운 연구 성과, 규제 당국의 승인에 힘입어 괄목할 만한 발전을 거듭하고 있습니다. 주요 발전으로는 플라즈마 기반 의료기기의 도입, 암 치료에서 플라즈마 응용의 발전, 의료와 학술기관 간의 연구 협력 증가를 들 수 있습니다. 향후 시장 성장은 기술 발전, 규제적 지원, 플라즈마의 치료 가능성에 대한 지속적인 연구에 의해 형성될 것입니다.

• 플라즈마 의료기기의 FDA 승인: 미국 식품의약국(FDA)의 플라즈마 기반 의료기기의 승인은 시장에서 중요한 진전입니다. 상처 치유, 피부 치료, 멸균을 위한 장비가 의료진에게 더 쉽게 접근할 수 있게 되었습니다. 이번 규제 승인은 임상 현장에서 플라즈마 기술을 보다 광범위하게 채택할 수 있는 길을 열어주며, 플라즈마 의료의 성장을 가속화하고 있습니다.
• 혈장 암 치료의 획기적인 발전: 혈장 기반 암 치료에서 중요한 진전이 이루어지고 있으며, 암세포 사멸을 유도하는 유망한 연구 결과가 발표되었습니다. 비침습적으로 종양을 표적화하여 치료하는 플라즈마의 능력이 주목받고 있으며, 현재 진행 중인 임상시험을 통해 다양한 유형의 암에 대한 효능이 검증되고 있습니다. 성공할 경우, 혈장암 치료는 종양학 분야에서 획기적인 치료법이 될 것으로 기대되며, 환자들에게 새로운 치료 옵션을 제공할 것으로 예측됩니다.
• 새로운 플라즈마 의료기기 개발: 여러 기업이 상처 치유부터 치과 치료까지 다양한 용도로 보다 효율적인 신형 플라즈마 의료기기를 개발하고 있습니다. 이 장비들은 보다 신속하고 효과적인 치료를 제공하여 환자의 치료 결과를 개선하고 의료 비용을 절감할 수 있도록 설계되었습니다. 이러한 장비의 개발은 전 세계 의료 현장에서 플라즈마 의료의 보급 확대에 기여하고 있습니다.
• 의료와 연구기관의 협력: 의료기관과 연구기관 간의 협력 강화로 플라즈마 치료법 개발이 가속화되고 있습니다. 이러한 협력 관계는 새로운 플라즈마 치료법 개발 촉진, 임상시험 확대, 플라즈마 의료 기술 고도화에 필수적입니다. 이러한 파트너십은 플라즈마 의료를 기존 의료 시스템에 통합하여 시장 성장의 기반을 확고히 다지는 데 일조하고 있습니다.
• 멸균 및 감염 관리에서의 플라즈마 활용: 플라즈마 기반 멸균 기술은 의료 및 병원 환경에서 인지도가 높아지고 있습니다. 플라즈마는 수술기구, 표면, 심지어 공기까지 살균할 수 있으며, 의료시설의 감염관리에 효과적인 수단입니다. 의료 관련 감염이 여전히 심각한 문제로 대두되고 있는 가운데, 플라즈마 멸균 솔루션은 기존 방식에 대한 유망한 대안으로 떠오르고 있습니다.

이러한 최근 추세로 인해 플라즈마 의료는 의료 분야에서 실용적이고 효과적인 치료 옵션으로 확고히 자리매김하고 있습니다. FDA 승인, 암 치료의 발전, 새로운 의료기기 개발 및 협력 강화로 인해 시장의 성장과 보급이 가속화되고 있습니다. 플라즈마 의료가 계속 진화하고 있는 가운데, 다양한 의료 분야에서의 치료 가능성은 더욱 확대될 것이며, 더 많은 임상 적용과 시장 점유율 확대가 기대됩니다.

목차

제1장 개요

제2장 시장 개요

• 배경과 분류
• 공급망

제3장 시장 동향과 예측 분석

• 업계 촉진요인과 과제
• PESTLE 분석
• 특허 분석
• 규제 환경

제4장 세계의 플라즈마 의료 시장 : 유형별

• 매력 분석 : 유형별
• 용량 결합형 방전
• 유도 결합형 방전
• 플라즈마 제트

제5장 세계의 플라즈마 의료 시장 : 용도별

• 매력 분석 : 용도별
• 생물학적 제염
• 치료 용도
• 기타

제6장 지역 분석

제7장 북미의 플라즈마 의료 시장

• 북미의 플라즈마 의료 시장 : 유형별
• 북미의 플라즈마 의료 시장 : 용도별
• 미국의 플라즈마 의료 시장
• 멕시코의 플라즈마 의료 시장
• 캐나다의 플라즈마 의료 시장

제8장 유럽의 플라즈마 의료 시장

• 유럽의 플라즈마 의료 시장 : 유형별
• 유럽의 플라즈마 의료 시장 : 용도별
• 독일의 플라즈마 의료 시장
• 프랑스의 플라즈마 의료 시장
• 스페인의 플라즈마 의료 시장
• 이탈리아의 플라즈마 의료 시장
• 영국의 플라즈마 의료 시장

제9장 아시아태평양의 플라즈마 의료 시장

• 아시아태평양의 플라즈마 의료 시장 : 유형별
• 아시아태평양의 플라즈마 의료 시장 : 용도별
• 일본의 플라즈마 의료 시장
• 인도의 플라즈마 의료 시장
• 중국의 플라즈마 의료 시장
• 한국의 플라즈마 의료 시장
• 인도네시아의 플라즈마 의료 시장

제10장 기타 지역(ROW)의 플라즈마 의료 시장

• ROW의 플라즈마 의료 시장 : 유형별
• ROW의 플라즈마 의료 시장 : 용도별
• 중동의 플라즈마 의료 시장
• 남미의 플라즈마 의료 시장
• 아프리카의 플라즈마 의료 시장

제11장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석
• 시장 점유율 분석

제12장 기회와 전략 분석

• 밸류체인 분석
• 성장 기회 분석
• 세계의 플라즈마 의료 시장의 새로운 동향
• 전략 분석

제13장 밸류체인에서 주요 기업의 개요

• 경쟁 분석
• US Medical Innovations
• Plasmacure
• Neoplas Med GMBH
• Plasma Surgical
• Cold Plasmatech GMBH

제14장 부록

영문목차

The future of the global plasma medicine market looks promising with opportunities in the biological decontamination, therapeutic applications, and others markets. The global plasma medicine market is expected to grow with a CAGR of 15.2% from 2025 to 2031. The major drivers for this market are the rising demand for non-invasive treatments in wound healing and cancer., the increasing focus on infection control and biological decontamination methods., and the trend toward personalized medicine.

• Lucintel forecasts that, within the type category, inductively coupled discharges is expected to witness the highest growth over the forecast period.
• Within the application category, therapeutic applications is expected to witness the highest growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Plasma Medicine Market

The plasma medicine market is evolving with several emerging trends that are reshaping its applications and growth potential. Key trends include the integration of plasma-based technologies into mainstream healthcare, increasing focus on non-invasive treatments, the rise of personalized medicine, advancements in plasma sterilization techniques, and the growing number of research and clinical trials.

• Non-Invasive Treatments and Therapeutics: Plasma medicine is gaining attention for its non-invasive nature, particularly in wound healing and dermatology. Plasma-based therapies are being designed to treat conditions without the need for surgical intervention. This trend is reshaping patient care, making treatments more accessible and reducing recovery times. The non-invasive nature of plasma technologies is contributing to the growing adoption of plasma-based medical devices globally.
• Advancements in Plasma Sterilization: Plasma-based sterilization technologies are becoming increasingly popular in the medical field, especially for sterilizing surgical tools and hospital environments. Plasma sterilization offers advantages over traditional methods by being more efficient and environmentally friendly. It has the potential to reduce the risk of infection, lower healthcare-associated costs, and improve overall patient outcomes, making it a key trend in healthcare and public health.
• Plasma-based Cancer Treatments: Plasma medicine is expanding into oncology, with research focusing on the use of plasma to treat cancer cells. Studies suggest that plasma can induce apoptosis in cancer cells, offering a promising non-invasive alternative to traditional cancer treatments. Ongoing clinical trials and experimental studies are paving the way for plasma-based cancer therapies, and this emerging trend could revolutionize cancer care in the future.
• Personalized Plasma Medicine: The trend toward personalized medicine is influencing the development of plasma therapies, where treatments are tailored to the individual's specific needs. Plasma medicine can be customized for different skin types, wound conditions, or diseases, improving the effectiveness of the therapy. As research progresses, plasma therapies will be increasingly adapted to meet the unique requirements of patients, enhancing patient outcomes and satisfaction.
• Increased R&D and Clinical Trials: The growing investment in research and development, coupled with an increasing number of clinical trials, is accelerating the growth of plasma medicine. Research institutions, hospitals, and pharmaceutical companies are investing in studies to better understand the mechanisms of plasma and its diverse applications. The increasing number of clinical trials is likely to drive innovation and the commercialization of plasma-based medical products, boosting market growth.

These emerging trends are significantly transforming the plasma medicine market. The non-invasive nature of plasma treatments is enhancing patient experience, while advancements in plasma sterilization and cancer treatment have broad implications for the medical field. Personalized medicine and the rise in clinical trials will further accelerate innovation and adoption, reshaping the market landscape and contributing to broader acceptance and usage of plasma-based therapies.

Recent Developments in the Plasma Medicine Market

The plasma medicine market is seeing significant advancements, driven by innovations in technology, new research findings, and regulatory approvals. Key developments include the introduction of plasma-based medical devices, advancements in plasma applications for cancer treatment, and increasing research collaborations between healthcare providers and academic institutions. The market's future growth will be shaped by technological progress, regulatory support, and continued research into plasma's therapeutic potential.

• FDA Approvals for Plasma Medical Devices: The approval of plasma-based medical devices by the U.S. Food and Drug Administration (FDA) has been a major development in the market. Devices for wound healing, dermatological treatments, and sterilization are now more accessible to healthcare providers. This regulatory validation has opened the door for wider adoption of plasma technologies in the clinical setting, accelerating the growth of plasma medicine.
• Breakthroughs in Plasma Cancer Therapy: Significant breakthroughs have been made in plasma-based cancer treatments, with research showing promising results in inducing cancer cell death. Plasma's ability to target and treat tumors non-invasively is gaining attention, and ongoing clinical trials are exploring its efficacy in various cancer types. If successful, plasma cancer therapy could become a game-changer in oncology, offering patients a new avenue of treatment.
• Development of New Plasma Medical Devices: Several companies are developing new, more efficient plasma medical devices for applications ranging from wound healing to dental care. These devices are designed to provide quicker and more effective treatments, improving patient outcomes and reducing healthcare costs. The development of these devices is contributing to the growing adoption of plasma medicine in medical practices worldwide.
• Collaboration Between Healthcare and Research Institutions: Increasing collaboration between medical institutions and research organizations is accelerating the development of plasma therapies. These collaborations are essential for driving forward new plasma-based treatment modalities, expanding clinical trials, and refining the technology behind plasma medicine. These partnerships are helping to integrate plasma medicine into existing healthcare systems and establishing a strong foundation for market growth.
• Plasma for Sterilization and Infection Control: Plasma-based sterilization technologies are gaining recognition in medical and hospital environments. Plasma can sterilize surgical instruments, surfaces, and even air, making it an effective tool for infection control in healthcare settings. As healthcare-associated infections continue to be a significant concern, plasma sterilization solutions are emerging as a promising alternative to traditional methods.

These recent developments are helping to solidify plasma medicine's position as a viable and effective treatment option in the healthcare industry. FDA approvals, advances in cancer therapy, new device developments, and increased collaboration are accelerating market growth and adoption. As plasma medicine continues to evolve, its therapeutic potential across various medical fields is expected to expand, resulting in greater clinical applications and a larger market share.

Strategic Growth Opportunities in the Plasma Medicine Market

The plasma medicine market presents numerous growth opportunities across various medical applications. These opportunities are driven by technological innovations, increasing demand for non-invasive treatments, and advancements in clinical research. The key areas for growth include wound healing, cancer treatment, dental care, sterilization, and regenerative medicine.

• Wound Healing Applications: Plasma medicine offers significant growth potential in the wound healing market. Plasma-based therapies can speed up the healing of chronic and diabetic wounds, making them a promising option for patients with slow-healing conditions. As demand for non-invasive wound healing treatments rises, plasma technology is poised to become a key player in this field, expanding its market share.
• Cancer Treatment Advancements: Plasma's potential in cancer treatment is driving growth in the oncology segment. Studies suggest that plasma can selectively target cancer cells without harming healthy tissue, offering a non-invasive alternative to traditional cancer therapies. As research continues, plasma-based cancer treatments could provide new options for patients and revolutionize cancer care.
• Dental Applications: Plasma medicine is gaining popularity in the dental industry for applications such as sterilization, root canal treatments, and oral infections. Plasma-based therapies offer effective, non-invasive solutions for dental care, reducing recovery times and improving patient comfort. The growing focus on non-invasive dental treatments is expected to drive significant market growth in this sector.
• Sterilization and Infection Control: Plasma technology's ability to sterilize medical equipment, hospital surfaces, and even air offers substantial growth opportunities in infection control. As hospitals and healthcare providers focus on reducing healthcare-associated infections, plasma-based sterilization solutions are expected to become a critical component in infection prevention strategies, fostering growth in this segment.
• Regenerative Medicine: Plasma's potential in regenerative medicine, particularly in tissue repair and skin regeneration, represents a promising area for growth. Plasma is being investigated for its ability to stimulate tissue regeneration, offering a non-invasive alternative for patients with injuries or degenerative conditions. Continued research and innovation in regenerative medicine will likely drive further market expansion.

These growth opportunities are contributing to the expansion of the plasma medicine market. As plasma technologies are increasingly adopted in wound healing, cancer treatment, dental care, sterilization, and regenerative medicine, the market is set to experience significant growth. These applications, coupled with ongoing research and innovation, will reshape the landscape of the plasma medicine market, unlocking new revenue streams and fostering widespread adoption.

Plasma Medicine Market Driver and Challenges

The growth of the plasma medicine market is influenced by a variety of technological, economic, and regulatory factors. Key drivers include advancements in plasma technology, increasing demand for non-invasive therapies, and regulatory approvals. However, challenges such as high research and development costs, regulatory hurdles, and limited awareness could impact the market's growth trajectory. Addressing these issues will be crucial for maximizing the potential of plasma medicine.

The factors responsible for driving the Plasma Medicine market include:

1. Technological Advancements: Continuous advancements in plasma generation technology, device development, and therapeutic applications are driving market growth. These innovations are making plasma medicine more effective, efficient, and accessible across various medical fields.

2. Increasing Demand for Non-Invasive Treatments: The growing preference for non-invasive therapies in areas like wound healing, dermatology, and cancer treatment is driving the adoption of plasma-based solutions, improving patient outcomes and satisfaction.

3. Regulatory Support and Approvals: The increasing number of regulatory approvals for plasma-based medical devices and therapies is fostering confidence in the market. This approval process is unlocking new opportunities for market players and healthcare providers.

4. Rising Healthcare Costs and Focus on Efficiency: Plasma medicine's cost-effectiveness and ability to streamline treatment processes are appealing to healthcare providers looking for more efficient solutions, especially in the context of rising healthcare costs.

5. Rising Incidence of Chronic Diseases: The growing prevalence of chronic diseases like diabetes, which often lead to chronic wounds, is fueling demand for plasma-based wound healing and regeneration therapies.

Challenges in the Plasma Medicine market are:

1. High Research and Development Costs: The significant costs associated with plasma medicine research and development can hinder the pace of innovation and the widespread adoption of plasma therapies.

2. Regulatory Barriers and Delays: While regulatory approvals are essential for market growth, lengthy approval processes, particularly for new plasma-based therapies, can delay commercialization and market penetration.

3. Limited Public Awareness: Plasma medicine is still relatively new, and limited awareness among healthcare providers and patients can slow down adoption. Education and awareness initiatives will be vital for market growth.

The plasma medicine market is growing rapidly, driven by technological advancements, regulatory support, and the increasing demand for non-invasive therapies. However, high R&D costs, regulatory hurdles, and limited awareness remain challenges that need to be addressed. Overcoming these obstacles will be key to unlocking the full potential of plasma medicine and facilitating its adoption across various medical fields.

List of Plasma Medicine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies plasma medicine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the plasma medicine companies profiled in this report include-

• US Medical Innovations
• Plasmacure
• Neoplas Med GMBH
• Plasma Surgical
• Cold Plasmatech GMBH

Plasma Medicine Market by Segment

The study includes a forecast for the global plasma medicine market by type, application, and region.

Plasma Medicine Market by Type [Value from 2019 to 2031]:

• Capacitively Coupled Discharges
• Inductively Coupled Discharges
• Plasma Jets

Plasma Medicine Market by Application [Value from 2019 to 2031]:

• Biological Decontamination
• Therapeutic Applications
• Others

Plasma Medicine Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Plasma Medicine Market

The plasma medicine market is gaining significant momentum, driven by advancements in medical technologies, growing interest in non-invasive treatments, and applications across various therapeutic fields such as dermatology, oncology, and wound healing. Key countries like the United States, China, Germany, India, and Japan are making significant strides in the development, approval, and adoption of plasma-based therapies. This market is expected to expand rapidly as plasma technology continues to show promising clinical applications.

• United States: In the United States, plasma medicine is gaining traction, particularly in dermatology and wound healing. Recent developments include FDA-approved plasma-based medical devices and innovations in plasma-based cancer treatment. American research institutions are exploring plasma's potential in treating skin conditions, infections, and promoting tissue regeneration. With growing investment in R&D and clinical trials, the U.S. is positioning itself as a leader in plasma medicine commercialization and adoption.
• China: China is rapidly adopting plasma medicine, with advancements being made in the use of plasma for wound care, dermatology, and oral health. The government has supported research into plasma applications in medical treatments, and the increasing demand for non-invasive therapies is pushing plasma-based solutions forward. Chinese manufacturers are innovating and producing affordable plasma medical devices, contributing to the broader availability of plasma medicine in healthcare settings.
• Germany: Germany stands out as a European leader in plasma medicine, with key research initiatives aimed at integrating plasma technologies into clinical treatments for cancer, skin conditions, and chronic wounds. The country has invested heavily in both fundamental and applied research to expand plasma-based therapies. German companies are at the forefront of developing and commercializing plasma medical devices, helping establish Germany as a central hub for plasma medicine in Europe.
• India: India's plasma medicine market is expanding, particularly in the areas of wound healing, dental care, and skin treatment. The rising demand for cost-effective, non-invasive treatments is driving the market's growth. Indian researchers and clinicians are increasingly exploring the therapeutic potential of plasma, with more clinical trials underway. Though adoption is still in its early stages, there is significant potential for growth in the coming years, especially in underserved regions.
• Japan: Japan is making notable progress in the use of plasma medicine, with a strong focus on wound healing, sterilization, and skin treatments. Plasma-based technologies are being increasingly integrated into medical devices, and Japanese companies are leading the development of equipment for plasma therapy. Research institutions are also conducting trials to explore plasma's potential in oncology and regenerative medicine, positioning Japan as a key player in the Asian plasma medicine market.

Features of the Global Plasma Medicine Market

• Market Size Estimates: Plasma medicine market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2023) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Plasma medicine market size by type, application, and region in terms of value ($B).
• Regional Analysis: Plasma medicine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the plasma medicine market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the plasma medicine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the plasma medicine market by type (capacitively coupled discharges, inductively coupled discharges, and plasma jets), application (biological decontamination, therapeutic applications, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Plasma Medicine Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Capacitively Coupled Discharges: Trends and Forecast (2019-2031)
• 4.4 Inductively Coupled Discharges: Trends and Forecast (2019-2031)
• 4.5 Plasma Jets: Trends and Forecast (2019-2031)

5. Global Plasma Medicine Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Biological Decontamination: Trends and Forecast (2019-2031)
• 5.4 Therapeutic Applications: Trends and Forecast (2019-2031)
• 5.5 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Plasma Medicine Market by Region

7. North American Plasma Medicine Market

• 7.1 Overview
• 7.2 North American Plasma Medicine Market by type
• 7.3 North American Plasma Medicine Market by application
• 7.4 United States Plasma Medicine Market
• 7.5 Mexican Plasma Medicine Market
• 7.6 Canadian Plasma Medicine Market

8. European Plasma Medicine Market

• 8.1 Overview
• 8.2 European Plasma Medicine Market by type
• 8.3 European Plasma Medicine Market by application
• 8.4 German Plasma Medicine Market
• 8.5 French Plasma Medicine Market
• 8.6 Spanish Plasma Medicine Market
• 8.7 Italian Plasma Medicine Market
• 8.8 United Kingdom Plasma Medicine Market

9. APAC Plasma Medicine Market

• 9.1 Overview
• 9.2 APAC Plasma Medicine Market by type
• 9.3 APAC Plasma Medicine Market by application
• 9.4 Japanese Plasma Medicine Market
• 9.5 Indian Plasma Medicine Market
• 9.6 Chinese Plasma Medicine Market
• 9.7 South Korean Plasma Medicine Market
• 9.8 Indonesian Plasma Medicine Market

10. ROW Plasma Medicine Market

• 10.1 Overview
• 10.2 ROW Plasma Medicine Market by type
• 10.3 ROW Plasma Medicine Market by application
• 10.4 Middle Eastern Plasma Medicine Market
• 10.5 South American Plasma Medicine Market
• 10.6 African Plasma Medicine Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Plasma Medicine Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 US Medical Innovations
  • Company Overview
  • Plasma Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Plasmacure
  • Company Overview
  • Plasma Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Neoplas Med GMBH
  • Company Overview
  • Plasma Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Plasma Surgical
  • Company Overview
  • Plasma Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Cold Plasmatech GMBH
  • Company Overview
  • Plasma Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us